Navigation Links
New Study Recognizes Halogen Customer for Best Practices in Employee Performance and Talent Management
Date:3/27/2008

OTTAWA, March 27 /PRNewswire/ - Halogen Software Inc., a leading provider of web-based employee performance and talent management software, has sponsored an IDC case study which profiles Florida-based CPA firm, O'Sullivan Creel. It was selected for this study based on its best-practice driven approach to employee performance and talent management, which includes the use of Halogen's product suite.

The case study, "Transforming Employee Performance Management: A Case Study on O'Sullivan Creel," finds that automating the management of employee performance can reduce turnover, significantly improve savings and drive adoption and efficiency.

Following the rollout of the Halogen solution, independent survey results from the McGladrey network indicated a 38 percent improvement in employees' understanding of the link between the work they do and how they are paid. Employees now have a clear roadmap for their success in the firm and O'Sullivan Creel has higher employee satisfaction - a key driver in retaining top performers.

"Employee performance and talent management systems offer more than just automation. This case study is a good example how these systems can be used to drive value for the organization and support recruitment and retention efforts as well," says Krista Collins, Research Analyst, Canadian IT Innovation & Export, IDC.

O'Sullivan Creel selected Halogen eAppraisal and Multi-Rater based on the flexibility of the solution, as it could be configured without IT or vendor involvement. Since rolling out the solution, under the leadership of partner Kathy Anthony, the firm has realized a number of benefits including productivity gains, improved quality of appraisals and greater transparency into the process.

"Given where we want our company to go, we could not accomplish it without Halogen," said Kathy Anthony, PHR, Partner, O'Sullivan Creel. "I believe the performance management culture that we have built using Halogen's solutions will ensure we meet our strategic vision."

The study can be downloaded at: http://www.halogensoftware.com/resources/white-papers/whitepapers_download.php?WhichWhitepaper=10

About Halogen Software

A recognized industry leader with over 1000 customers worldwide, Halogen Software makes powerful, simple-to-use and affordable employee performance and talent management applications. The company offers a complete suite of web-based products that automate, simplify and integrate employee performance management, 360/multi-rater feedback, compensation management, succession planning and learning management. Halogen's offering makes HR best-practices accessible to companies of all sizes and its healthcare, financial services and professional services specific suites meet the unique needs of these industries. Halogen is consistently recognized by the industry and its customers for its exceptional implementation and support services, and has won multiple awards for its corporate leadership and product innovation, including HR Technology Product of the Year. For more information, visit http://www.halogensoftware.com.


'/>"/>
SOURCE HALOGEN SOFTWARE
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Kline Study: Better Brushing Habits Boost European Oral Care Sales
4. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
5. NASA study will help stop stowaways to Mars
6. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
7. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
8. Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201
9. Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes
10. Quigley Corporation Releases Update on Quigley Pharmas Phase IIb Clinical Study of QR-333 in Diabetic Peripheral Neuropathy
11. Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Colo. , March 23, 2017  GlobeImmune, Inc. ... agreement for the sale of 12,835,490 shares of its ... NantWorks  ecosystem of companies. In connection with the sale of ... $100,000 in cash and issue to GlobeImmune 200,000 shares, ... stock. "We are pleased to enter ...
(Date:3/23/2017)... New York , March 23, 2017 ... blood plasma products and derivatives market is fragmented due to the presence ... players, such as Proliant, Thermo Fisher , and Sigma-Aldrich, compete ... leader, these three companies, collectively, held more than 76% of this ... ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... up human tissue regeneration from small lab samples to full-size tissues, bones, even ... to establish a vascular system that delivers blood deep into the developing tissue. ...
(Date:3/22/2017)... 2017   iSpecimen ®, the marketplace ... Pathology Service (DPS), a full-service anatomic pathology reference ... United States , has joined a program offered ... (DHIN) to make human biospecimens and associated data ... program, announced in 2015 as a collaboration between iSpecimen ...
Breaking Biology Technology:
(Date:2/16/2017)...  Genos, a community for personal genetic discovery ... Laboratory Accreditation from the College of American Pathologists ... that meet stringent requirements around quality, accuracy and ... "Genos is committed to maintaining the highest ... to be receiving CAP accreditation," said Jill ...
(Date:2/13/2017)... 13, 2017  RSA Conference -- RSA, a Dell ... designed to enhance fraud detection and investigation across ... RSA Fraud & Risk Intelligence Suite. The new ... additional insights from internal and external sources as ... their customers from targeted cybercrime attacks. ...
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
Breaking Biology News(10 mins):